nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—XDH—Cisplatin—lung cancer	0.15	0.225	CbGbCtD
Procarbazine—CYP1B1—Erlotinib—lung cancer	0.135	0.203	CbGbCtD
Procarbazine—CYP1B1—Paclitaxel—lung cancer	0.124	0.186	CbGbCtD
Procarbazine—XDH—Doxorubicin—lung cancer	0.1	0.151	CbGbCtD
Procarbazine—CYP1B1—Docetaxel—lung cancer	0.0895	0.134	CbGbCtD
Procarbazine—CYP1B1—Doxorubicin—lung cancer	0.0667	0.1	CbGbCtD
Procarbazine—CYP1B1—Benzo(a)pyrene metabolism—AKR1C1—lung cancer	0.00298	0.0374	CbGpPWpGaD
Procarbazine—XDH—Purine catabolism—CAT—lung cancer	0.00276	0.0346	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—VIMP—lung cancer	0.00223	0.028	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—NFE2L2—lung cancer	0.00195	0.0245	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—GSTA1—lung cancer	0.00179	0.0224	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—GCLC—lung cancer	0.00168	0.0211	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—UGT1A1—lung cancer	0.00166	0.0208	CbGpPWpGaD
Procarbazine—CYP1B1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—lung cancer	0.00158	0.0199	CbGpPWpGaD
Procarbazine—CYP1B1—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.00144	0.0181	CbGpPWpGaD
Procarbazine—CYP1B1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—lung cancer	0.00144	0.0181	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—PRDX1—lung cancer	0.00144	0.018	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—NQO1—lung cancer	0.00141	0.0177	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—JUNB—lung cancer	0.0014	0.0176	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—HSD17B10—lung cancer	0.00139	0.0175	CbGpPWpGaD
Procarbazine—XDH—Nucleotide metabolism—RRM1—lung cancer	0.0012	0.0151	CbGpPWpGaD
Procarbazine—CYP1B1—Tamoxifen metabolism—CYP2A6—lung cancer	0.0012	0.015	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—CAT—lung cancer	0.00115	0.0144	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—NQO1—lung cancer	0.00114	0.0143	CbGpPWpGaD
Procarbazine—Ibuprofen—UGT1A1—lung cancer	0.0011	0.31	CrCbGaD
Procarbazine—XDH—Oxidative Stress—SOD2—lung cancer	0.00109	0.0136	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—CYP1A1—lung cancer	0.00107	0.0135	CbGpPWpGaD
Procarbazine—XDH—Purine metabolism—CAT—lung cancer	0.00106	0.0133	CbGpPWpGaD
Procarbazine—Ibuprofen—CXCL8—lung cancer	0.00104	0.293	CrCbGaD
Procarbazine—XDH—Oxidative Stress—CYP1A1—lung cancer	0.00103	0.0129	CbGpPWpGaD
Procarbazine—CYP1B1—Tamoxifen metabolism—CYP2E1—lung cancer	0.00102	0.0128	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.00089	0.0112	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000878	0.011	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—GSTA2—lung cancer	0.000875	0.011	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—GSTM1—lung cancer	0.000873	0.011	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—CYP1A1—lung cancer	0.000827	0.0104	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—UGT1A1—lung cancer	0.000784	0.00984	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—AHR—lung cancer	0.000763	0.00957	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—AHR—lung cancer	0.000763	0.00957	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—lung cancer	0.000744	0.00933	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—NFE2L2—lung cancer	0.000744	0.00933	CbGpPWpGaD
Procarbazine—CYP1B1—Tamoxifen metabolism—CYP1A1—lung cancer	0.000731	0.00918	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000722	0.00905	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—HPGDS—lung cancer	0.000667	0.00837	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—GCLC—lung cancer	0.000639	0.00802	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—HPGDS—lung cancer	0.000624	0.00783	CbGpPWpGaD
Procarbazine—Atenolol—ABCB1—lung cancer	0.000577	0.163	CrCbGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—JUN—lung cancer	0.000576	0.00722	CbGpPWpGaD
Procarbazine—CYP1B1—Melatonin metabolism and effects—CYP1A1—lung cancer	0.000565	0.00709	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—CYP2E1—lung cancer	0.000544	0.00682	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—NQO1—lung cancer	0.000538	0.00675	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—NQO1—lung cancer	0.000538	0.00675	CbGpPWpGaD
Procarbazine—XDH—Nucleotide metabolism—CAT—lung cancer	0.000534	0.0067	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUNB—lung cancer	0.000534	0.0067	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000517	0.00649	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.00051	0.0064	CbGpPWpGaD
Procarbazine—XDH—Nucleotide metabolism—TYMS—lung cancer	0.00051	0.0064	CbGpPWpGaD
Procarbazine—CYP1B1—Endogenous sterols—POMC—lung cancer	0.000507	0.00636	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—STAT3—lung cancer	0.000498	0.00625	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—CAT—lung cancer	0.000485	0.00608	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—SOD2—lung cancer	0.00046	0.00577	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.00044	0.00552	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—CAT—lung cancer	0.000436	0.00547	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000434	0.00544	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—CNDP2—lung cancer	0.000424	0.00532	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GSTM2—lung cancer	0.000424	0.00532	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000419	0.00526	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTM2—lung cancer	0.000418	0.00524	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—lung cancer	0.000414	0.0052	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—lung cancer	0.000391	0.0049	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—CYP1A1—lung cancer	0.000391	0.0049	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—CYP1A1—lung cancer	0.000391	0.0049	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—CYP2A7—lung cancer	0.000383	0.00481	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP2A7—lung cancer	0.000378	0.00474	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—APOA1—lung cancer	0.000372	0.00467	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—CYP1A1—lung cancer	0.000365	0.00458	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000356	0.00447	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GSTA3—lung cancer	0.000342	0.00429	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTA3—lung cancer	0.000337	0.00423	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000316	0.00396	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GSTA4—lung cancer	0.000312	0.00392	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000312	0.00391	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTA4—lung cancer	0.000308	0.00387	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GSTA2—lung cancer	0.000304	0.00382	CbGpPWpGaD
Procarbazine—Ibuprofen—PTGS2—lung cancer	0.000303	0.0854	CrCbGaD
Procarbazine—XDH—Selenium Micronutrient Network—ALB—lung cancer	0.000295	0.0037	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GSTA1—lung cancer	0.000294	0.00369	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—RB1—lung cancer	0.000283	0.00355	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—AKR1C1—lung cancer	0.000277	0.00348	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—UGT1A1—lung cancer	0.000273	0.00343	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—MAP2K1—lung cancer	0.000271	0.0034	CbGpPWpGaD
Procarbazine—Ibuprofen—ALB—lung cancer	0.00027	0.0761	CrCbGaD
Procarbazine—CYP1B1—Metapathway biotransformation—UGT1A1—lung cancer	0.000269	0.00338	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000269	0.00337	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—PTGS2—lung cancer	0.000258	0.00324	CbGpPWpGaD
Procarbazine—Ibuprofen—ABCB1—lung cancer	0.000257	0.0726	CrCbGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000256	0.00321	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—MDM2—lung cancer	0.000241	0.00302	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—RAF1—lung cancer	0.00024	0.00301	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000235	0.00295	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—lung cancer	0.000232	0.00291	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—HPGDS—lung cancer	0.000232	0.00291	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GSTT1—lung cancer	0.000225	0.00283	CbGpPWpGaD
Procarbazine—XDH—Metabolism—AZIN2—lung cancer	0.000223	0.0028	CbGpPWpGaD
Procarbazine—XDH—Metabolism—COL4A3BP—lung cancer	0.000223	0.0028	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GCLC—lung cancer	0.000223	0.00279	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—CYP2A6—lung cancer	0.000223	0.00279	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—PTGS2—lung cancer	0.000217	0.00273	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	0.000215	0.0027	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	0.000209	0.00263	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000204	0.00255	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1A—lung cancer	0.000203	0.00255	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—EP300—lung cancer	0.000193	0.00242	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	0.000193	0.00242	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000191	0.0024	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ATP5H—lung cancer	0.00019	0.00238	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—CYP2E1—lung cancer	0.000189	0.00238	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	0.000188	0.00236	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—SRC—lung cancer	0.000188	0.00236	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP2E1—lung cancer	0.000187	0.00234	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	0.000183	0.0023	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—lung cancer	0.000181	0.00227	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PLBD1—lung cancer	0.000169	0.00212	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—MYC—lung cancer	0.000168	0.00211	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	0.000165	0.00207	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—lung cancer	0.000165	0.00207	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000158	0.00199	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GSTP1—lung cancer	0.000156	0.00196	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—lung cancer	0.000156	0.00195	CbGpPWpGaD
Procarbazine—XDH—Metabolism—HSD17B10—lung cancer	0.000155	0.00194	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTP1—lung cancer	0.000154	0.00193	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CKB—lung cancer	0.000144	0.00181	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GSTM1—lung cancer	0.000143	0.0018	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTM1—lung cancer	0.000141	0.00178	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—IL6—lung cancer	0.000141	0.00176	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—CYP1A1—lung cancer	0.000136	0.00171	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GSTM2—lung cancer	0.000135	0.0017	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CNDP2—lung cancer	0.000135	0.0017	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP1A1—lung cancer	0.000134	0.00168	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—lung cancer	0.000132	0.00166	CbGpPWpGaD
Procarbazine—XDH—Metabolism—MTMR3—lung cancer	0.000132	0.00165	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PGAM1—lung cancer	0.000128	0.00161	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CYP2A7—lung cancer	0.000122	0.00154	CbGpPWpGaD
Procarbazine—XDH—Metabolism—SDC4—lung cancer	0.00012	0.0015	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—COL4A3BP—lung cancer	0.00012	0.0015	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—AZIN2—lung cancer	0.00012	0.0015	CbGpPWpGaD
Procarbazine—Confusional state—Paclitaxel—lung cancer	0.000112	0.000447	CcSEcCtD
Procarbazine—Gastrointestinal pain—Irinotecan—lung cancer	0.000112	0.000444	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000112	0.0014	CbGpPWpGaD
Procarbazine—Oedema—Paclitaxel—lung cancer	0.000111	0.000443	CcSEcCtD
Procarbazine—Paraesthesia—Cisplatin—lung cancer	0.000111	0.000443	CcSEcCtD
Procarbazine—Thrombocytopenia—Etoposide—lung cancer	0.000111	0.000443	CcSEcCtD
Procarbazine—Tachycardia—Etoposide—lung cancer	0.000111	0.000441	CcSEcCtD
Procarbazine—Infection—Paclitaxel—lung cancer	0.000111	0.00044	CcSEcCtD
Procarbazine—Hyperhidrosis—Etoposide—lung cancer	0.00011	0.000437	CcSEcCtD
Procarbazine—Feeling abnormal—Gemcitabine—lung cancer	0.00011	0.000436	CcSEcCtD
Procarbazine—Shock—Paclitaxel—lung cancer	0.00011	0.000436	CcSEcCtD
Procarbazine—Dizziness—Vinorelbine—lung cancer	0.00011	0.000436	CcSEcCtD
Procarbazine—Photosensitivity reaction—Methotrexate—lung cancer	0.000109	0.000435	CcSEcCtD
Procarbazine—Thrombocytopenia—Paclitaxel—lung cancer	0.000109	0.000434	CcSEcCtD
Procarbazine—XDH—Metabolism—RRM1—lung cancer	0.000109	0.00137	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GSTA3—lung cancer	0.000109	0.00137	CbGpPWpGaD
Procarbazine—Tachycardia—Paclitaxel—lung cancer	0.000109	0.000433	CcSEcCtD
Procarbazine—Anorexia—Etoposide—lung cancer	0.000108	0.000431	CcSEcCtD
Procarbazine—Abdominal pain—Irinotecan—lung cancer	0.000108	0.00043	CcSEcCtD
Procarbazine—Body temperature increased—Irinotecan—lung cancer	0.000108	0.00043	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000108	0.00043	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000108	0.00136	CbGpPWpGaD
Procarbazine—Decreased appetite—Cisplatin—lung cancer	0.000108	0.000429	CcSEcCtD
Procarbazine—Hyperhidrosis—Paclitaxel—lung cancer	0.000108	0.000429	CcSEcCtD
Procarbazine—Pneumonia—Methotrexate—lung cancer	0.000107	0.000427	CcSEcCtD
Procarbazine—Anaemia—Docetaxel—lung cancer	0.000107	0.000426	CcSEcCtD
Procarbazine—Drowsiness—Methotrexate—lung cancer	0.000107	0.000425	CcSEcCtD
Procarbazine—Anorexia—Paclitaxel—lung cancer	0.000106	0.000423	CcSEcCtD
Procarbazine—Hypotension—Etoposide—lung cancer	0.000106	0.000422	CcSEcCtD
Procarbazine—Pain—Cisplatin—lung cancer	0.000106	0.000422	CcSEcCtD
Procarbazine—Vomiting—Vinorelbine—lung cancer	0.000105	0.000419	CcSEcCtD
Procarbazine—Body temperature increased—Gemcitabine—lung cancer	0.000105	0.000419	CcSEcCtD
Procarbazine—Rash—Vinorelbine—lung cancer	0.000105	0.000416	CcSEcCtD
Procarbazine—Dermatitis—Vinorelbine—lung cancer	0.000104	0.000415	CcSEcCtD
Procarbazine—Hypotension—Paclitaxel—lung cancer	0.000104	0.000414	CcSEcCtD
Procarbazine—Stomatitis—Methotrexate—lung cancer	0.000104	0.000414	CcSEcCtD
Procarbazine—Headache—Vinorelbine—lung cancer	0.000104	0.000413	CcSEcCtD
Procarbazine—Syncope—Docetaxel—lung cancer	0.000104	0.000413	CcSEcCtD
Procarbazine—Dysphagia—Doxorubicin—lung cancer	0.000104	0.000412	CcSEcCtD
Procarbazine—Leukopenia—Docetaxel—lung cancer	0.000104	0.000412	CcSEcCtD
Procarbazine—Eosinophilia—Doxorubicin—lung cancer	0.000103	0.000408	CcSEcCtD
Procarbazine—XDH—Metabolism—B4GALT5—lung cancer	0.000103	0.00129	CbGpPWpGaD
Procarbazine—Sweating—Methotrexate—lung cancer	0.000102	0.000407	CcSEcCtD
Procarbazine—Feeling abnormal—Cisplatin—lung cancer	0.000102	0.000407	CcSEcCtD
Procarbazine—Paraesthesia—Etoposide—lung cancer	0.000102	0.000406	CcSEcCtD
Procarbazine—Haematuria—Methotrexate—lung cancer	0.000102	0.000405	CcSEcCtD
Procarbazine—Loss of consciousness—Docetaxel—lung cancer	0.000102	0.000405	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—ATP5H—lung cancer	0.000102	0.00128	CbGpPWpGaD
Procarbazine—Pancreatitis—Doxorubicin—lung cancer	0.000102	0.000404	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000102	0.000404	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—POMC—lung cancer	0.000101	0.00127	CbGpPWpGaD
Procarbazine—Somnolence—Etoposide—lung cancer	0.000101	0.000402	CcSEcCtD
Procarbazine—Cough—Docetaxel—lung cancer	0.000101	0.000402	CcSEcCtD
Procarbazine—Angina pectoris—Doxorubicin—lung cancer	0.000101	0.000402	CcSEcCtD
Procarbazine—Insomnia—Paclitaxel—lung cancer	0.000101	0.000401	CcSEcCtD
Procarbazine—Epistaxis—Methotrexate—lung cancer	0.000101	0.0004	CcSEcCtD
Procarbazine—Hypersensitivity—Irinotecan—lung cancer	0.000101	0.0004	CcSEcCtD
Procarbazine—Convulsion—Docetaxel—lung cancer	0.0001	0.000399	CcSEcCtD
Procarbazine—Paraesthesia—Paclitaxel—lung cancer	0.0001	0.000398	CcSEcCtD
Procarbazine—Hypertension—Docetaxel—lung cancer	0.0001	0.000397	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTA4—lung cancer	9.98e-05	0.00125	CbGpPWpGaD
Procarbazine—Somnolence—Paclitaxel—lung cancer	9.91e-05	0.000394	CcSEcCtD
Procarbazine—Decreased appetite—Etoposide—lung cancer	9.88e-05	0.000393	CcSEcCtD
Procarbazine—Arthralgia—Docetaxel—lung cancer	9.86e-05	0.000392	CcSEcCtD
Procarbazine—Myalgia—Docetaxel—lung cancer	9.86e-05	0.000392	CcSEcCtD
Procarbazine—Pancytopenia—Doxorubicin—lung cancer	9.85e-05	0.000392	CcSEcCtD
Procarbazine—Nausea—Vinorelbine—lung cancer	9.85e-05	0.000391	CcSEcCtD
Procarbazine—Body temperature increased—Cisplatin—lung cancer	9.81e-05	0.00039	CcSEcCtD
Procarbazine—Asthenia—Irinotecan—lung cancer	9.81e-05	0.00039	CcSEcCtD
Procarbazine—Fatigue—Etoposide—lung cancer	9.8e-05	0.00039	CcSEcCtD
Procarbazine—Constipation—Etoposide—lung cancer	9.72e-05	0.000387	CcSEcCtD
Procarbazine—Pain—Etoposide—lung cancer	9.72e-05	0.000387	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTA2—lung cancer	9.72e-05	0.00122	CbGpPWpGaD
Procarbazine—Decreased appetite—Paclitaxel—lung cancer	9.69e-05	0.000385	CcSEcCtD
Procarbazine—Dry mouth—Docetaxel—lung cancer	9.64e-05	0.000383	CcSEcCtD
Procarbazine—Haemoglobin—Methotrexate—lung cancer	9.64e-05	0.000383	CcSEcCtD
Procarbazine—Fatigue—Paclitaxel—lung cancer	9.61e-05	0.000382	CcSEcCtD
Procarbazine—Haemorrhage—Methotrexate—lung cancer	9.59e-05	0.000381	CcSEcCtD
Procarbazine—Pollakiuria—Doxorubicin—lung cancer	9.58e-05	0.000381	CcSEcCtD
Procarbazine—Asthenia—Gemcitabine—lung cancer	9.55e-05	0.00038	CcSEcCtD
Procarbazine—Constipation—Paclitaxel—lung cancer	9.53e-05	0.000379	CcSEcCtD
Procarbazine—Pain—Paclitaxel—lung cancer	9.53e-05	0.000379	CcSEcCtD
Procarbazine—Confusional state—Docetaxel—lung cancer	9.53e-05	0.000379	CcSEcCtD
Procarbazine—Photosensitivity reaction—Doxorubicin—lung cancer	9.47e-05	0.000376	CcSEcCtD
Procarbazine—Oedema—Docetaxel—lung cancer	9.45e-05	0.000376	CcSEcCtD
Procarbazine—Pruritus—Gemcitabine—lung cancer	9.42e-05	0.000375	CcSEcCtD
Procarbazine—Infection—Docetaxel—lung cancer	9.39e-05	0.000373	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTA1—lung cancer	9.38e-05	0.00118	CbGpPWpGaD
Procarbazine—Feeling abnormal—Etoposide—lung cancer	9.37e-05	0.000373	CcSEcCtD
Procarbazine—Diarrhoea—Irinotecan—lung cancer	9.35e-05	0.000372	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	9.35e-05	0.00117	CbGpPWpGaD
Procarbazine—Pneumonia—Doxorubicin—lung cancer	9.3e-05	0.00037	CcSEcCtD
Procarbazine—Gastrointestinal pain—Etoposide—lung cancer	9.3e-05	0.00037	CcSEcCtD
Procarbazine—Shock—Docetaxel—lung cancer	9.3e-05	0.00037	CcSEcCtD
Procarbazine—XDH—Metabolism—ABCC3—lung cancer	9.27e-05	0.00116	CbGpPWpGaD
Procarbazine—Thrombocytopenia—Docetaxel—lung cancer	9.25e-05	0.000368	CcSEcCtD
Procarbazine—Drowsiness—Doxorubicin—lung cancer	9.25e-05	0.000368	CcSEcCtD
Procarbazine—Tachycardia—Docetaxel—lung cancer	9.22e-05	0.000367	CcSEcCtD
Procarbazine—Feeling abnormal—Paclitaxel—lung cancer	9.19e-05	0.000365	CcSEcCtD
Procarbazine—Hypersensitivity—Cisplatin—lung cancer	9.14e-05	0.000364	CcSEcCtD
Procarbazine—Gastrointestinal pain—Paclitaxel—lung cancer	9.12e-05	0.000362	CcSEcCtD
Procarbazine—Diarrhoea—Gemcitabine—lung cancer	9.11e-05	0.000362	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—PLBD1—lung cancer	9.07e-05	0.00114	CbGpPWpGaD
Procarbazine—Neuropathy peripheral—Doxorubicin—lung cancer	9.06e-05	0.00036	CcSEcCtD
Procarbazine—Dizziness—Irinotecan—lung cancer	9.04e-05	0.000359	CcSEcCtD
Procarbazine—Urticaria—Etoposide—lung cancer	9.03e-05	0.000359	CcSEcCtD
Procarbazine—Stomatitis—Doxorubicin—lung cancer	9.01e-05	0.000358	CcSEcCtD
Procarbazine—Jaundice—Doxorubicin—lung cancer	9.01e-05	0.000358	CcSEcCtD
Procarbazine—Anorexia—Docetaxel—lung cancer	9.01e-05	0.000358	CcSEcCtD
Procarbazine—Abdominal pain—Etoposide—lung cancer	8.99e-05	0.000357	CcSEcCtD
Procarbazine—Body temperature increased—Etoposide—lung cancer	8.99e-05	0.000357	CcSEcCtD
Procarbazine—XDH—Metabolism—AKR1C1—lung cancer	8.98e-05	0.00113	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	8.92e-05	0.00112	CbGpPWpGaD
Procarbazine—Asthenia—Cisplatin—lung cancer	8.91e-05	0.000354	CcSEcCtD
Procarbazine—Sweating—Doxorubicin—lung cancer	8.86e-05	0.000352	CcSEcCtD
Procarbazine—Urticaria—Paclitaxel—lung cancer	8.86e-05	0.000352	CcSEcCtD
Procarbazine—Hypotension—Docetaxel—lung cancer	8.83e-05	0.000351	CcSEcCtD
Procarbazine—Haematuria—Doxorubicin—lung cancer	8.82e-05	0.000351	CcSEcCtD
Procarbazine—Body temperature increased—Paclitaxel—lung cancer	8.81e-05	0.00035	CcSEcCtD
Procarbazine—Abdominal pain—Paclitaxel—lung cancer	8.81e-05	0.00035	CcSEcCtD
Procarbazine—Epistaxis—Doxorubicin—lung cancer	8.72e-05	0.000347	CcSEcCtD
Procarbazine—XDH—Metabolism—UGT1A1—lung cancer	8.72e-05	0.00109	CbGpPWpGaD
Procarbazine—Vomiting—Irinotecan—lung cancer	8.69e-05	0.000346	CcSEcCtD
Procarbazine—Rash—Irinotecan—lung cancer	8.62e-05	0.000343	CcSEcCtD
Procarbazine—Dermatitis—Irinotecan—lung cancer	8.61e-05	0.000342	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Docetaxel—lung cancer	8.61e-05	0.000342	CcSEcCtD
Procarbazine—Chills—Methotrexate—lung cancer	8.6e-05	0.000342	CcSEcCtD
Procarbazine—Headache—Irinotecan—lung cancer	8.56e-05	0.000341	CcSEcCtD
Procarbazine—Insomnia—Docetaxel—lung cancer	8.55e-05	0.00034	CcSEcCtD
Procarbazine—Diarrhoea—Cisplatin—lung cancer	8.49e-05	0.000338	CcSEcCtD
Procarbazine—Paraesthesia—Docetaxel—lung cancer	8.49e-05	0.000337	CcSEcCtD
Procarbazine—Alopecia—Methotrexate—lung cancer	8.47e-05	0.000337	CcSEcCtD
Procarbazine—Vomiting—Gemcitabine—lung cancer	8.47e-05	0.000337	CcSEcCtD
Procarbazine—XDH—Metabolism—GNG11—lung cancer	8.41e-05	0.00105	CbGpPWpGaD
Procarbazine—Somnolence—Docetaxel—lung cancer	8.4e-05	0.000334	CcSEcCtD
Procarbazine—Rash—Gemcitabine—lung cancer	8.4e-05	0.000334	CcSEcCtD
Procarbazine—Dermatitis—Gemcitabine—lung cancer	8.39e-05	0.000334	CcSEcCtD
Procarbazine—Hypersensitivity—Etoposide—lung cancer	8.38e-05	0.000333	CcSEcCtD
Procarbazine—Haemoglobin—Doxorubicin—lung cancer	8.34e-05	0.000332	CcSEcCtD
Procarbazine—Headache—Gemcitabine—lung cancer	8.34e-05	0.000332	CcSEcCtD
Procarbazine—Haemorrhage—Doxorubicin—lung cancer	8.3e-05	0.00033	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—HSD17B10—lung cancer	8.29e-05	0.00104	CbGpPWpGaD
Procarbazine—Decreased appetite—Docetaxel—lung cancer	8.21e-05	0.000327	CcSEcCtD
Procarbazine—Hypersensitivity—Paclitaxel—lung cancer	8.21e-05	0.000327	CcSEcCtD
Procarbazine—Asthenia—Etoposide—lung cancer	8.16e-05	0.000324	CcSEcCtD
Procarbazine—Fatigue—Docetaxel—lung cancer	8.15e-05	0.000324	CcSEcCtD
Procarbazine—Nausea—Irinotecan—lung cancer	8.12e-05	0.000323	CcSEcCtD
Procarbazine—Constipation—Docetaxel—lung cancer	8.08e-05	0.000321	CcSEcCtD
Procarbazine—Pain—Docetaxel—lung cancer	8.08e-05	0.000321	CcSEcCtD
Procarbazine—Pruritus—Etoposide—lung cancer	8.04e-05	0.00032	CcSEcCtD
Procarbazine—XDH—Metabolism—ALDOA—lung cancer	8.01e-05	0.001	CbGpPWpGaD
Procarbazine—Asthenia—Paclitaxel—lung cancer	8e-05	0.000318	CcSEcCtD
Procarbazine—Nausea—Gemcitabine—lung cancer	7.91e-05	0.000314	CcSEcCtD
Procarbazine—Vomiting—Cisplatin—lung cancer	7.89e-05	0.000314	CcSEcCtD
Procarbazine—Pruritus—Paclitaxel—lung cancer	7.89e-05	0.000314	CcSEcCtD
Procarbazine—Rash—Cisplatin—lung cancer	7.83e-05	0.000311	CcSEcCtD
Procarbazine—Dermatitis—Cisplatin—lung cancer	7.82e-05	0.000311	CcSEcCtD
Procarbazine—Feeling abnormal—Docetaxel—lung cancer	7.79e-05	0.00031	CcSEcCtD
Procarbazine—Diarrhoea—Etoposide—lung cancer	7.78e-05	0.000309	CcSEcCtD
Procarbazine—XDH—Metabolism—NCOA3—lung cancer	7.77e-05	0.000975	CbGpPWpGaD
Procarbazine—Gastrointestinal pain—Docetaxel—lung cancer	7.73e-05	0.000307	CcSEcCtD
Procarbazine—Anaemia—Methotrexate—lung cancer	7.71e-05	0.000307	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—CKB—lung cancer	7.71e-05	0.000967	CbGpPWpGaD
Procarbazine—Flushing—Doxorubicin—lung cancer	7.7e-05	0.000306	CcSEcCtD
Procarbazine—Diarrhoea—Paclitaxel—lung cancer	7.63e-05	0.000303	CcSEcCtD
Procarbazine—XDH—Metabolism—ADCY1—lung cancer	7.56e-05	0.000949	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ABCG2—lung cancer	7.56e-05	0.000949	CbGpPWpGaD
Procarbazine—Dizziness—Etoposide—lung cancer	7.52e-05	0.000299	CcSEcCtD
Procarbazine—Abdominal pain—Docetaxel—lung cancer	7.47e-05	0.000297	CcSEcCtD
Procarbazine—Body temperature increased—Docetaxel—lung cancer	7.47e-05	0.000297	CcSEcCtD
Procarbazine—Leukopenia—Methotrexate—lung cancer	7.47e-05	0.000297	CcSEcCtD
Procarbazine—Chills—Doxorubicin—lung cancer	7.45e-05	0.000296	CcSEcCtD
Procarbazine—Arrhythmia—Doxorubicin—lung cancer	7.42e-05	0.000295	CcSEcCtD
Procarbazine—XDH—Metabolism—ENO2—lung cancer	7.41e-05	0.00093	CbGpPWpGaD
Procarbazine—XDH—Metabolism—HPGDS—lung cancer	7.41e-05	0.00093	CbGpPWpGaD
Procarbazine—Dizziness—Paclitaxel—lung cancer	7.37e-05	0.000293	CcSEcCtD
Procarbazine—Nausea—Cisplatin—lung cancer	7.37e-05	0.000293	CcSEcCtD
Procarbazine—XDH—Metabolism—PPP2R1B—lung cancer	7.37e-05	0.000924	CbGpPWpGaD
Procarbazine—Alopecia—Doxorubicin—lung cancer	7.34e-05	0.000292	CcSEcCtD
Procarbazine—Cough—Methotrexate—lung cancer	7.28e-05	0.00029	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—CNDP2—lung cancer	7.25e-05	0.000909	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTM2—lung cancer	7.25e-05	0.000909	CbGpPWpGaD
Procarbazine—Convulsion—Methotrexate—lung cancer	7.23e-05	0.000287	CcSEcCtD
Procarbazine—Vomiting—Etoposide—lung cancer	7.23e-05	0.000287	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTT1—lung cancer	7.19e-05	0.000902	CbGpPWpGaD
Procarbazine—Rash—Etoposide—lung cancer	7.17e-05	0.000285	CcSEcCtD
Procarbazine—Dermatitis—Etoposide—lung cancer	7.16e-05	0.000285	CcSEcCtD
Procarbazine—Headache—Etoposide—lung cancer	7.12e-05	0.000283	CcSEcCtD
Procarbazine—XDH—Metabolism—GCLC—lung cancer	7.11e-05	0.000892	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CYP2A6—lung cancer	7.11e-05	0.000892	CbGpPWpGaD
Procarbazine—Arthralgia—Methotrexate—lung cancer	7.1e-05	0.000282	CcSEcCtD
Procarbazine—Myalgia—Methotrexate—lung cancer	7.1e-05	0.000282	CcSEcCtD
Procarbazine—Tension—Doxorubicin—lung cancer	7.09e-05	0.000282	CcSEcCtD
Procarbazine—Vomiting—Paclitaxel—lung cancer	7.09e-05	0.000282	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—MTMR3—lung cancer	7.05e-05	0.000885	CbGpPWpGaD
Procarbazine—Rash—Paclitaxel—lung cancer	7.03e-05	0.00028	CcSEcCtD
Procarbazine—Dermatitis—Paclitaxel—lung cancer	7.02e-05	0.000279	CcSEcCtD
Procarbazine—Nervousness—Doxorubicin—lung cancer	7.02e-05	0.000279	CcSEcCtD
Procarbazine—Headache—Paclitaxel—lung cancer	6.98e-05	0.000278	CcSEcCtD
Procarbazine—Hypersensitivity—Docetaxel—lung cancer	6.96e-05	0.000277	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—PGAM1—lung cancer	6.87e-05	0.000862	CbGpPWpGaD
Procarbazine—Confusional state—Methotrexate—lung cancer	6.87e-05	0.000273	CcSEcCtD
Procarbazine—Asthenia—Docetaxel—lung cancer	6.78e-05	0.00027	CcSEcCtD
Procarbazine—Infection—Methotrexate—lung cancer	6.77e-05	0.000269	CcSEcCtD
Procarbazine—Nausea—Etoposide—lung cancer	6.75e-05	0.000269	CcSEcCtD
Procarbazine—XDH—Metabolism—ENO1—lung cancer	6.74e-05	0.000845	CbGpPWpGaD
Procarbazine—Pruritus—Docetaxel—lung cancer	6.69e-05	0.000266	CcSEcCtD
Procarbazine—Anaemia—Doxorubicin—lung cancer	6.68e-05	0.000266	CcSEcCtD
Procarbazine—Thrombocytopenia—Methotrexate—lung cancer	6.67e-05	0.000265	CcSEcCtD
Procarbazine—Nausea—Paclitaxel—lung cancer	6.62e-05	0.000263	CcSEcCtD
Procarbazine—Hyperhidrosis—Methotrexate—lung cancer	6.58e-05	0.000262	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—CYP2A7—lung cancer	6.55e-05	0.000822	CbGpPWpGaD
Procarbazine—Anorexia—Methotrexate—lung cancer	6.49e-05	0.000258	CcSEcCtD
Procarbazine—Syncope—Doxorubicin—lung cancer	6.48e-05	0.000258	CcSEcCtD
Procarbazine—Leukopenia—Doxorubicin—lung cancer	6.47e-05	0.000257	CcSEcCtD
Procarbazine—Diarrhoea—Docetaxel—lung cancer	6.47e-05	0.000257	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—SDC4—lung cancer	6.41e-05	0.000805	CbGpPWpGaD
Procarbazine—Hypotension—Methotrexate—lung cancer	6.36e-05	0.000253	CcSEcCtD
Procarbazine—Loss of consciousness—Doxorubicin—lung cancer	6.35e-05	0.000253	CcSEcCtD
Procarbazine—Cough—Doxorubicin—lung cancer	6.31e-05	0.000251	CcSEcCtD
Procarbazine—Convulsion—Doxorubicin—lung cancer	6.26e-05	0.000249	CcSEcCtD
Procarbazine—Dizziness—Docetaxel—lung cancer	6.25e-05	0.000248	CcSEcCtD
Procarbazine—Hypertension—Doxorubicin—lung cancer	6.24e-05	0.000248	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Methotrexate—lung cancer	6.21e-05	0.000247	CcSEcCtD
Procarbazine—Insomnia—Methotrexate—lung cancer	6.16e-05	0.000245	CcSEcCtD
Procarbazine—Arthralgia—Doxorubicin—lung cancer	6.15e-05	0.000245	CcSEcCtD
Procarbazine—Myalgia—Doxorubicin—lung cancer	6.15e-05	0.000245	CcSEcCtD
Procarbazine—Anxiety—Doxorubicin—lung cancer	6.13e-05	0.000244	CcSEcCtD
Procarbazine—Paraesthesia—Methotrexate—lung cancer	6.12e-05	0.000243	CcSEcCtD
Procarbazine—Somnolence—Methotrexate—lung cancer	6.05e-05	0.000241	CcSEcCtD
Procarbazine—XDH—Metabolism—CYP2E1—lung cancer	6.04e-05	0.000758	CbGpPWpGaD
Procarbazine—Dry mouth—Doxorubicin—lung cancer	6.02e-05	0.000239	CcSEcCtD
Procarbazine—Vomiting—Docetaxel—lung cancer	6.01e-05	0.000239	CcSEcCtD
Procarbazine—XDH—Metabolism—NQO1—lung cancer	5.98e-05	0.00075	CbGpPWpGaD
Procarbazine—Rash—Docetaxel—lung cancer	5.96e-05	0.000237	CcSEcCtD
Procarbazine—Dermatitis—Docetaxel—lung cancer	5.95e-05	0.000237	CcSEcCtD
Procarbazine—Confusional state—Doxorubicin—lung cancer	5.95e-05	0.000236	CcSEcCtD
Procarbazine—Decreased appetite—Methotrexate—lung cancer	5.92e-05	0.000235	CcSEcCtD
Procarbazine—Headache—Docetaxel—lung cancer	5.92e-05	0.000235	CcSEcCtD
Procarbazine—Oedema—Doxorubicin—lung cancer	5.9e-05	0.000234	CcSEcCtD
Procarbazine—Fatigue—Methotrexate—lung cancer	5.87e-05	0.000233	CcSEcCtD
Procarbazine—Infection—Doxorubicin—lung cancer	5.86e-05	0.000233	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—RRM1—lung cancer	5.84e-05	0.000733	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTA3—lung cancer	5.84e-05	0.000733	CbGpPWpGaD
Procarbazine—Pain—Methotrexate—lung cancer	5.82e-05	0.000232	CcSEcCtD
Procarbazine—Shock—Doxorubicin—lung cancer	5.8e-05	0.000231	CcSEcCtD
Procarbazine—Thrombocytopenia—Doxorubicin—lung cancer	5.77e-05	0.00023	CcSEcCtD
Procarbazine—Tachycardia—Doxorubicin—lung cancer	5.76e-05	0.000229	CcSEcCtD
Procarbazine—Hyperhidrosis—Doxorubicin—lung cancer	5.7e-05	0.000227	CcSEcCtD
Procarbazine—Anorexia—Doxorubicin—lung cancer	5.62e-05	0.000224	CcSEcCtD
Procarbazine—Nausea—Docetaxel—lung cancer	5.61e-05	0.000223	CcSEcCtD
Procarbazine—Feeling abnormal—Methotrexate—lung cancer	5.61e-05	0.000223	CcSEcCtD
Procarbazine—Gastrointestinal pain—Methotrexate—lung cancer	5.57e-05	0.000221	CcSEcCtD
Procarbazine—Hypotension—Doxorubicin—lung cancer	5.51e-05	0.000219	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—B4GALT5—lung cancer	5.49e-05	0.000689	CbGpPWpGaD
Procarbazine—Urticaria—Methotrexate—lung cancer	5.41e-05	0.000215	CcSEcCtD
Procarbazine—XDH—Metabolism—STK11—lung cancer	5.39e-05	0.000676	CbGpPWpGaD
Procarbazine—Abdominal pain—Methotrexate—lung cancer	5.38e-05	0.000214	CcSEcCtD
Procarbazine—Body temperature increased—Methotrexate—lung cancer	5.38e-05	0.000214	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.37e-05	0.000214	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—GSTA4—lung cancer	5.34e-05	0.00067	CbGpPWpGaD
Procarbazine—Insomnia—Doxorubicin—lung cancer	5.33e-05	0.000212	CcSEcCtD
Procarbazine—Paraesthesia—Doxorubicin—lung cancer	5.3e-05	0.000211	CcSEcCtD
Procarbazine—Somnolence—Doxorubicin—lung cancer	5.24e-05	0.000208	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	5.22e-05	0.000655	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTA2—lung cancer	5.21e-05	0.000653	CbGpPWpGaD
Procarbazine—Decreased appetite—Doxorubicin—lung cancer	5.13e-05	0.000204	CcSEcCtD
Procarbazine—Fatigue—Doxorubicin—lung cancer	5.08e-05	0.000202	CcSEcCtD
Procarbazine—Pain—Doxorubicin—lung cancer	5.04e-05	0.000201	CcSEcCtD
Procarbazine—Constipation—Doxorubicin—lung cancer	5.04e-05	0.000201	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—GSTA1—lung cancer	5.02e-05	0.00063	CbGpPWpGaD
Procarbazine—Hypersensitivity—Methotrexate—lung cancer	5.02e-05	0.0002	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTP1—lung cancer	4.98e-05	0.000625	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ABCC3—lung cancer	4.97e-05	0.000623	CbGpPWpGaD
Procarbazine—Asthenia—Methotrexate—lung cancer	4.89e-05	0.000194	CcSEcCtD
Procarbazine—Feeling abnormal—Doxorubicin—lung cancer	4.86e-05	0.000193	CcSEcCtD
Procarbazine—XDH—Metabolism—CAT—lung cancer	4.85e-05	0.000609	CbGpPWpGaD
Procarbazine—Gastrointestinal pain—Doxorubicin—lung cancer	4.82e-05	0.000192	CcSEcCtD
Procarbazine—Pruritus—Methotrexate—lung cancer	4.82e-05	0.000192	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—AKR1C1—lung cancer	4.81e-05	0.000604	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ABCB1—lung cancer	4.72e-05	0.000592	CbGpPWpGaD
Procarbazine—Urticaria—Doxorubicin—lung cancer	4.69e-05	0.000186	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—UGT1A1—lung cancer	4.67e-05	0.000586	CbGpPWpGaD
Procarbazine—Body temperature increased—Doxorubicin—lung cancer	4.66e-05	0.000185	CcSEcCtD
Procarbazine—Abdominal pain—Doxorubicin—lung cancer	4.66e-05	0.000185	CcSEcCtD
Procarbazine—Diarrhoea—Methotrexate—lung cancer	4.66e-05	0.000185	CcSEcCtD
Procarbazine—XDH—Metabolism—TYMS—lung cancer	4.63e-05	0.000581	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GSTM1—lung cancer	4.58e-05	0.000575	CbGpPWpGaD
Procarbazine—Dizziness—Methotrexate—lung cancer	4.5e-05	0.000179	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—GNG11—lung cancer	4.5e-05	0.000565	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.48e-05	0.000562	CbGpPWpGaD
Procarbazine—Hypersensitivity—Doxorubicin—lung cancer	4.35e-05	0.000173	CcSEcCtD
Procarbazine—XDH—Metabolism—CYP1A1—lung cancer	4.34e-05	0.000545	CbGpPWpGaD
Procarbazine—Vomiting—Methotrexate—lung cancer	4.33e-05	0.000172	CcSEcCtD
Procarbazine—XDH—Metabolism—ERCC2—lung cancer	4.31e-05	0.00054	CbGpPWpGaD
Procarbazine—Rash—Methotrexate—lung cancer	4.29e-05	0.000171	CcSEcCtD
Procarbazine—Dermatitis—Methotrexate—lung cancer	4.29e-05	0.000171	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—ALDOA—lung cancer	4.29e-05	0.000538	CbGpPWpGaD
Procarbazine—Headache—Methotrexate—lung cancer	4.27e-05	0.00017	CcSEcCtD
Procarbazine—Asthenia—Doxorubicin—lung cancer	4.23e-05	0.000168	CcSEcCtD
Procarbazine—Pruritus—Doxorubicin—lung cancer	4.17e-05	0.000166	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—NCOA3—lung cancer	4.16e-05	0.000522	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.09e-05	0.000513	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ADCY1—lung cancer	4.05e-05	0.000508	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ABCG2—lung cancer	4.05e-05	0.000508	CbGpPWpGaD
Procarbazine—Nausea—Methotrexate—lung cancer	4.05e-05	0.000161	CcSEcCtD
Procarbazine—Diarrhoea—Doxorubicin—lung cancer	4.04e-05	0.00016	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—HPGDS—lung cancer	3.97e-05	0.000498	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ENO2—lung cancer	3.97e-05	0.000498	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PPP2R1B—lung cancer	3.95e-05	0.000495	CbGpPWpGaD
Procarbazine—Dizziness—Doxorubicin—lung cancer	3.9e-05	0.000155	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.89e-05	0.000489	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTT1—lung cancer	3.85e-05	0.000483	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GCLC—lung cancer	3.81e-05	0.000478	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP2A6—lung cancer	3.81e-05	0.000478	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.79e-05	0.000476	CbGpPWpGaD
Procarbazine—Vomiting—Doxorubicin—lung cancer	3.75e-05	0.000149	CcSEcCtD
Procarbazine—XDH—Metabolism—APOA1—lung cancer	3.73e-05	0.000467	CbGpPWpGaD
Procarbazine—Rash—Doxorubicin—lung cancer	3.72e-05	0.000148	CcSEcCtD
Procarbazine—Dermatitis—Doxorubicin—lung cancer	3.72e-05	0.000148	CcSEcCtD
Procarbazine—Headache—Doxorubicin—lung cancer	3.69e-05	0.000147	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—ENO1—lung cancer	3.61e-05	0.000453	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.6e-05	0.000451	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.55e-05	0.000445	CbGpPWpGaD
Procarbazine—Nausea—Doxorubicin—lung cancer	3.5e-05	0.000139	CcSEcCtD
Procarbazine—XDH—Metabolism—PIK3CG—lung cancer	3.4e-05	0.000427	CbGpPWpGaD
Procarbazine—XDH—Metabolism—POMC—lung cancer	3.24e-05	0.000406	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP2E1—lung cancer	3.24e-05	0.000406	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—NQO1—lung cancer	3.2e-05	0.000402	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CREBBP—lung cancer	3.15e-05	0.000396	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.13e-05	0.000393	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.11e-05	0.00039	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PIK3CD—lung cancer	2.99e-05	0.000375	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ALB—lung cancer	2.95e-05	0.00037	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—STK11—lung cancer	2.89e-05	0.000362	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.71e-05	0.00034	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTP1—lung cancer	2.67e-05	0.000335	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PIK3CB—lung cancer	2.61e-05	0.000327	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CAT—lung cancer	2.6e-05	0.000326	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.58e-05	0.000324	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PTGS2—lung cancer	2.58e-05	0.000324	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ABCB1—lung cancer	2.53e-05	0.000317	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—TYMS—lung cancer	2.48e-05	0.000311	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTM1—lung cancer	2.45e-05	0.000308	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP1A1—lung cancer	2.33e-05	0.000292	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ERCC2—lung cancer	2.31e-05	0.000289	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PTEN—lung cancer	2.25e-05	0.000283	CbGpPWpGaD
Procarbazine—XDH—Metabolism—EP300—lung cancer	2.15e-05	0.000269	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—APOA1—lung cancer	2e-05	0.00025	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.91e-05	0.00024	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PIK3CG—lung cancer	1.82e-05	0.000229	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—POMC—lung cancer	1.73e-05	0.000218	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CREBBP—lung cancer	1.69e-05	0.000212	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PIK3CD—lung cancer	1.6e-05	0.000201	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PIK3CA—lung cancer	1.59e-05	0.000199	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ALB—lung cancer	1.58e-05	0.000198	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PIK3CB—lung cancer	1.4e-05	0.000175	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PTGS2—lung cancer	1.38e-05	0.000174	CbGpPWpGaD
Procarbazine—XDH—Metabolism—AKT1—lung cancer	1.3e-05	0.000163	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PTEN—lung cancer	1.21e-05	0.000151	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—EP300—lung cancer	1.15e-05	0.000144	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PIK3CA—lung cancer	8.51e-06	0.000107	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—AKT1—lung cancer	6.95e-06	8.72e-05	CbGpPWpGaD
